Boston Scientific Corporation

BSX | NYSE

$43.22

+$1.24 (+2.95%)

Nov 2, 2026, 10:34 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
PE Ratio	48.65	70.89	53.50	103.10	61.34	-442.73
PEG Ratio	0.88	4.27	0.38	-2.93	-0.06	4.32
PS Ratio	7.03	7.85	5.90	5.22	5.08	5.14
PB Ratio	5.82	6.04	4.36	3.77	3.63	3.32
P/FCF Ratio	38.59	49.69	49.32	72.42	45.91	44.99
P/OCF Ratio	31.13	38.26	33.56	43.37	32.31	33.77
OCF/S Ratio	22.59	20.51	17.58	12.03	15.73	15.21
Debt / Equity Ratio	0.51	0.51	0.49	0.53	0.57	0.62
Quick Ratio	1.08	0.64	0.82	1.02	1.10	1.45
Current Ratio	1.62	1.08	1.32	1.51	1.48	1.82
Asset Turnover	0.46	0.43	0.41	0.39	0.37	0.32
Interest Coverage	11.38	6.81	8.02	3.93	5.51	1.28
Return on Equity	11.91%	8.52%	8.26%	3.97%	6.26%	-0.54%
Return on Assets	6.61%	4.71%	4.53%	2.15%	3.23%	-0.27%
Return on Invested Capital	8.78%	6.13%	5.69%	3.89%	6.58%	2.22%
Dividend Yield	n/a	n/a	0.03%	0.08%	0.09%	0.06%
Payout Ratio	n/a	n/a	1.76%	7.88%	5.29%	-34.15%
FCF Payout Ratio	n/a	n/a	1.90%	7.93%	4.90%	2.91%
Gross Profit Margin	69.01%	61.31%	62.02%	60.83%	62.76%	56.25%
Net Profit Margin	14.38%	11.07%	11.19%	5.50%	8.75%	-0.83%
Pretax Profit Margin	16.86%	13.63%	13.94%	9%	9.05%	-0.80%
Operating Profit Margin	19.78%	15.73%	15.32%	14.38%	16.17%	6.06%
FCF Margin	18.22%	15.79%	11.96%	7.21%	11.07%	11.42%
EBITDA Margin	25.42%	23.51%	24.25%	21.61%	21.18%	15.25%